Stem cell therapy: A novel approach for myocardial infarction

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Stem Cell Biology

Background:

• Myocardial infarction (MI) is a leading global cause of death.
• Previously, myocardium was considered incapable of self-repair.
• Emerging evidence highlights cardiac stem cells' regenerative potential.

Purpose of the Study:

• To review the potential of stem cell therapy for myocardial repair post-MI.
• To explore the role of stem cell-derived paracrine factors in cardiac regeneration.
• To evaluate evidence from preclinical and clinical studies.

Main Methods:

• Review of cellular, animal, and clinical studies on stem cell therapy for MI.
• Analysis of stem cell-derived paracrine factor mechanisms.
• Synthesis of current evidence on therapeutic efficacy.

Main Results:

• Resident cardiac stem cells possess regenerative capacity.
• Stem cell-derived paracrine factors influence ventricular remodeling, inflammation, and apoptosis.
• Evidence supports stem cell therapy's role in cardiomyocyte regeneration and neovascularization.

Conclusions:

• Stem cell therapy presents a novel therapeutic approach for MI.
• Paracrine factors are key mediators of stem cell-induced cardiac repair.
• Further clinical studies are warranted to establish efficacy for MI treatment.